A Philadelphia jury on Tuesday awarded $8 billion in punitive damages against Johnson & Johnson and one if its subsidiaries over a drug the companies made that the plaintiff's attorneys say is linked to the abnormal growth of female breast tissue in boys.
Johnson and Johnson immediately denounced the award after the jury's decision in the Court of Common pleas, saying it's "excessive and unfounded" and vowing immediate action to overturn it.